Celularity (CELU) Interest Coverage Ratio (2020 - 2025)
Celularity's (CELU) quarterly Interest Coverage Ratio came in at 24.59 in Q4 2025, down 380.16% year-over-year from 8.78 in Q4 2024, and down 181.56% quarter-over-quarter from 8.73 in Q3 2025.
Powered by 
Analysis
Celularity (CELU) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Interest Coverage Ratio for 5 consecutive years, with 24.59 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Interest Coverage Ratio fell 380.16% year-over-year to 24.59 in Q4 2025; TTM through Dec 2025 was 9.08, a 48.24% decrease from a year earlier, with the FY2025 full-year figure at 9.08, down 48.24% from the prior year.
- Interest Coverage Ratio was 24.59 for Q4 2025 at Celularity, down from 8.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 20.08 in Q4 2023 and troughed at 230.58 in Q1 2023.
- A 4-year average of 35.1 and a median of 8.45 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 289.91% in 2021 and sank 380.16% in 2025, its largest moves.
- Over 4 years, Interest Coverage Ratio stood at 19.7 in 2021, then soared by 201.95% to 20.08 in 2023, then plunged by 125.5% to 5.12 in 2024, then slumped by 380.16% to 24.59 in 2025.
- The last three Interest Coverage Ratio figures came in at 24.59 (Q4 2025), 8.73 (Q3 2025), and 8.16 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | -0.01 |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn | 9.95 |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | -3.63 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 7.67 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 2.71 |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | -24.59 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -24.59 |
| Sep 30, 2025 | -8.73 |
| Jun 30, 2025 | -8.16 |
| Mar 31, 2025 | -4.30 |
| Dec 31, 2024 | -5.12 |
| Sep 30, 2024 | -6.58 |
| Jun 30, 2024 | -6.56 |
| Mar 31, 2024 | -6.43 |
| Dec 31, 2023 | 20.08 |
| Sep 30, 2023 | -102.22 |
| Jun 30, 2023 | -38.47 |
| Mar 31, 2023 | -230.58 |
| Dec 31, 2021 | -19.70 |
| Sep 30, 2021 | 12.93 |
| Jun 30, 2021 | -74.19 |
| Mar 31, 2021 | -59.04 |
| Dec 31, 2020 | 15.27 |
| Sep 30, 2020 | -6.81 |